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Abbreviations: CM-cellulose: carboxymethylcellulose DMSO: dimethylsulfoxide He pes: N -2-hydroxyethyl-piperazine-N ' -2-ethanesulfonic acid RDEB: recessive dystrophic epidermolysis bullosa were acting to inhibit synthesis of the enzyme. However, an additional effect of these agents was encountered. Although the retinoids themselves had no direct collagenase inhibitory action, medium derived from cultures maintained in these retinoids showed direct inhibitory capacity which was dependent both on the concentration of retinoic acid and on the length of time in culture. The results suggest that the retinoic acids modulate collagenase in vitro by two mechanisms: by decreasing the synthesis of enzyme protein and by modulating the expression of an inhibitory molecule.
Collagenase is the rate-limiting enzyme in collagen degradation and is crucial for the initial characteristic cleavage of the collagen molecule [1] . Following this cleavage, at physiologic temperature the individual collagen chains become denatw·ed [2] and are further degraded by the gelatin-specific neutral protease, gelatinase [3] [4] [5] [6] [7] . For complete collagen degradation to occur in the skin, it is likely that the concerted, but sequential, actions of at least two enzymes-collagenase and gelatinase-are required [7] [8] [9] .
Although vitamin A (retinol) and its derivatives (retinoids) constitute a class of compounds with many diverse actions, particularly on epithelial cells [10] , their effects are not limited to this cell type. Thus, it is of interest that Brinckerhoff and coworkers [11, 12] have shown that both naturally occurring alltrans-retinoic acid and the synthetic retinoid, 13-cis-retinoic acid, inhibit collagenase expression in cultures of mesenchymal cells derived from human rheumatoid synovium. In other sys-terns, however, t h e effects of retinoids on various proteolytic enzymes differ, and this variability may depend on certain genetic or epigenetic ch aracteristics of the given cell strains. For example, in SV -40 transformed 3T3 cells, 10 J.LM retinoic acid has been shown to cause a 5-to 6-fold increase in plasminogen activator, while in nontransformed cells, this stimulation was not observed [13] . Furthermore, in one t h erap eutic trial employing 13-cis-retinoic acid in a heritable keratinizing disord er of the skin, the retinoid decreased both ,8-glucuronidase a nd cathepsin D but caused no change in neutral protease of the skin [14] .
In view of the modulatory effect of retinoic acid on rheumatoid synovial cells, we postulated that t he retinoids might exert an effect on proteases involved in t he t urnover of connective t issue in the skin. In addition, since certain pharmacologic agents-such as phenytoin-which inhibit collagenase synthesis in vitro [15] h ave been shown to ameliorate th e blistering and connective tissue fragility caused by excessive collagenase synthesis [16, 17) in the hereditary blistering disorder, recessive dystrophic epidermolysis bullosa (RDEB) [16, 18) , it seemed reasonable to postulate that other drugs which function as inhibitors of collagenase expression might be found to be therapeutically useful in this disease. In this study, we have employed human skin fibroblasts to examine the effects of retinoids on th e collagen degradative enzymes. Our major aims were threefold: (a) to determine th e effects of r etinoids on collagenase and gelatinolytic protease expression in vitro, (b) to extend the findin gs on collagenase to RDEB cells and, if possible, to utilize an in vitro system to develop a rationale for possible therapeutic use of the compounds in RDEB, and (c) to determine the m echanism(s) of action of selected compounds in modulating collagenase in vitro and to characterize the phenotypic variability in these mechanisms.
MATERIALS AND METHODS

Fibroblast Cultures
Skin fibroblast cultmes were established from normal volunteers a nd from patients with epidermolysis bullosa after obtaining informed consent in accorda nce with t he requirements of the Washington University Human Studies Committee (Table 1 ) . Cells were subcultivated in disposable plastic culture dishes or flasks (Falcon Plastics, Division of Bec ton Dickinson, Cockeysville, Maryland) in Dulbecco's modified Eagle's medium-high glucose plus glutamine with 30 mM Hepes buffer (pH 7.6) , 20% fetal calf serum, a nd 200 units of penicillin and 200 flg of streptomycin/ ml at 37° C in a 95% air:5% C0 2 atmosphere. In t hese experiments, fibroblasts were grown to early conflu ence (i.e., stationary), a cell density at which collagenase accumulation is greatest [19, 20] .
To determine t he effects of the various retinoids on collagenase and/ or gelatinolytic protease expression, serum-containing medium was removed, t he ce ll layers were washed 3 times with H a nks' balanced salt solution, a nd the cultures were maintained for 24-48 h in serum-free Dulbecco's modified Eagle's medium containing 10-7 to 10-5 M co ncentrations of the various retinoids or an appropriate amount of eth anol or 1 mo dimethylsufoxide (DMSO) as a solvent control, as described by Brinckerhoff et al [11] . Reti nol, and all-trans-retinoic acid were purchased from Sigma Chemical (St. Louis, Missouri) . The synthetic retinoids, 13cis-retinoic acid and Ro 10-9359, were generously provided by Dr. W. E. Scott of Hoffmann-La Roche (Nutley, N ew Jersey). Stock solu tions of all compounds were prepared at 10-3 M concentrations in ethanol or DMSO and were stor ed at -70°C until diluted with culture medium for use.
Enzyme Assays
For collagenase assay, huma n skin fibrob last culture medium was activated proteolytically with trypsin as described previously [21] . For each enzym e preparation, a range of trypsin concentrations (0.2-5 flg of t rypsin per 100 fll enzyme sample) was employed to ensure that ma ximal activity was measured. After preincubation with trypsin for 10 min at 25°C, at least a 5-fold molar excess of soybean trypsin inhibitor was added to inhibit furt her trypsin activity. Each mi..xtme was t hen assayed at 37°C in 0.05 M Tris-HCl (pH 7.5) in th e presence of 10 mM CaCb using native, reconstituted [ 14 C]glycine-labeled collagen fibrils containing 4000-7000 cpm per substrate gel [22] . The specific activity of the ['''C]collagen was 25,000 cpm/ mg. Ethanol and DMSO, in th e concentrations employed in these experiments, did not interfere with the assay.
The assay used to measure gelatinolytic activity was a slight modification of t hat described by Harris and Krane [3] . T he radioactive gelatin was prepared by thermally denaturing ['''C]glycine-labeled guin ea pig skin collagen at 60°C for 20 min. Following trypsin activation of the fibroblast cultme medium containing th e putative progelatinase at 37°C for 20 min, the mixture was incubated with th e [' 4 C]glycinelabeled gelatin at 37°C [7] . The reaction was terminated by the addition of 100% (w/ v) trichloroacetic acid to give a final concentration of 20%. After cooling on ice for 30 min, the reaction tubes were centrifuged at 12,000 g, and the supernatant fractions were counted in a liquid scintillation spectrometer [7] . Since DMSO was found to be a slight inhibitor of gelatinolytic activity, all experiments on the effects of t he retinoids on gelatinase expression were performed using ethanol as the solvent.
Inhibitor Assay
To determine th e capacity of the medium obtained from retinoidcontaining cult ures to inhibit collagenase activity directly, varying concentrations of medium wer e mixed with fully active, purified human skin collagenase, and the ent ire mixture was assayed using radioactive collagen fibrils as described a bove. For these experiments th e active collagenase was obtained from human skin explants grown in serumfree medium a nd purified by t he method of Stricklin et al [8] . The results were expressed as t he percent inhibition of exogenous collagenase activity by the retinoid-containing medium over that found in controls containing exogenous collagenase and an equal concentration of medium derived from cultures grown in the appropriate organic solvent (i.e., ethanol or DMSO). Direct addition of retinol or retinoids to the collagenase or gelatinase was not in itself inhibitory in these assays.
Radioimmunoassay of Collagenase
In order to assess th e capacity of the retinoids to inhibit collagenase synthesis, as reflected by a decrease in immunoreactive m aterial in the medium, immunoreactive collagenase was measured by a slight modification of the double antibody radioimmunoassay previously reported [23] . The procollagenase used as th e unlabeled standard and for iodination was pw·ified to homogeneity [8] . The antiserum prepared with this immunogen [9] gave a single immunoprecipitin band when reacted in gel diffusion analysis [24] eit her with the crude cult ure medium or with the electrophoretically homogeneous huma n skin collagenase. In addition, a gamma globulin preparation of the a ntiserum produced >90% inhibition of collagenase activity after reacting 2 h at 37°C compared with < 5% inhibition by a nonimmune gamma globulin preparation [9] . Standard radioimmunoassay curves were derived by incubating duplicate disposable plastic microfuge tubes (Beckman Instruments, Inc.) that contained a 1:2500 dilution of t he gamma globulin fraction of antiserum to human skin collagenase, 125 !-labeled human skin collagenase (-20,000 cpm/tube) , a nd 0-100 ng of electrophoretically homogeneous huma n skin collagenase in a total volume of 250 fll. After incubation for 24 h at 4°C, goat an tirabbit IgG was added in excess, and the resulting precipitates were isolated, washed, and counted in a single-cha nnel gamma scintillation spectrometer. Unknowns were assayed for e nzyme protein in an identical fashion using 150-fll portions of serial doubling dilutions of the enzyme preparations.
Controls in which nonimmune rabbit gamma globulin was substituted for specific antiserum were routinely included.
Other Assays
Total protein synthesis was determined in fibroblast cultures in the presence of either retinoids or solvent controls. Under serum-free conditions identical to those described above for assessing collagenase expression, a 3 H-labeled amino acid mixtw-e (10 1-'Ci/ml) was added for 24 h and total protein synthesis was determined as the amount of aH-Iabeled amino acids incorporated into 10% trichloroacetic acid-precipitable material in the medium and cells. The protein content of the cell layer was determined by the method of Lowry et a] (25] using a bovine serum albumin standard. Statistical analysis of the data was performed using Student's t-test.
RESULTS
Initially we investigated the capacity of varying concentrations of retinoic acid, when added to human skin fibroblast cultures, to inhibit the accumulation of collagenase in the culture medium. The data in Vol. 81, No.2 iments, both normal fibroblasts and cells from a genetically distinct type of epidermolysis bullosa, dominant epidermolysis bullosa simplex, served as controls ( Fig 1A) for comparison with the amount of collagenase in the medium of the RDEB cells. The degree of inhibition in the control cultures varied between 50 and 100% at the highest drug concentration. In the case of the 4 RDEB cell strains ( Fig 1B) , despite the fact that the initial collagenase levels in the medium were about 3-fold greater than in the control cells, 13-cis-retinoic acid also produced 70-100% inhibition. No differences were found between the normal and mutant cells in their capacity to respond to the retinoid.
The effect of retinoic acid on the expression of gelatinolytic activity was also examined, as shown for 2 of 7 such experiments (Fig 2) . In contrast to the case with collagenase, retinoic acid was significantly less effective at 0.5, 1, and 5 J..tM drug concentrations as an inhibitor of gelatinolytic protease accumulation in the medium with half-maximal inhibition occm-ring between 3 and 6 J..tM. At the highest concentration of retinoic acid tested (10 J..tM), the inhibitory effects on collagenase and the gelatinase were not significantly different. In these experiments, as well as those depicted in Fig 1, attempts to increase the retinoid concentration to 100 J..I.M resulted in apparent toxicity to the fibroblasts as manifested by marked granularity of the cytoplasm.
To compare the kinetic characteristics and the relative capacities of the two forms of retinoic acid-naturally occuning all-trans and synthetic 13-cis-in inhibiting collagenase and gelatinolytic protease expression, we utilized one concentration of drug (10 J..I.M) for varying times (24 and 48 h) in both normal and RDEB fibroblast cultures (Fig 3) . In the RDEB cultures, collagenase accumulated in the culture medium at about 3.5 times the rate of accumulation in normal cell cultmes ( Fig  3A,B) , a finding reflective of our previous studies which showed enhanced biosynthesis of this enzyme [17) . In these experiments, both 13-cis-and all-trans-retinoic acid inhibited collagenase expression by 40-60% at 24 h and by 60-80% at 48 h. The parent compound, retinol, failed to inhibit collagenase accumulation in the control cells ( Fig 3A) but produced -35% inhibition in the RDEB cells ( Fig 3B) . The reason for the different responsiveness to retinol in this particulru: experiment is at present unknown.
Since it has been suggested that the increased synthesis of collagenase in RDEB may represent a genetic characteristic of this disease [16] , we examined the synthesis and secretion of the presumed second enzyme in the collagen deg:radative pathway-a gelatinolytic protease (Fig 3C,D) . No significant differences were found between control and mutant cell strains in the rates of accumulation of this gelatinase in the absence of retinoids. Both 13-cisand all-trans-retinoic acid produced a 50-70% inhibition of gelatinase accumulation at 48 h. Retinol gave no significant inhibition (Fig 3C,D) . Since the expression of the gelatinolytic protease was equal in the two cell types, the data suggest that only the increase in t he rate of synthesis of collagenase served as a biochemical marker for discrimination ofRDEB.
We next performed additional experiments to determine the relative specificities of the various retinoids in inhibiting collagenase expression. To accomplish this, we measured the effect of a 1 J.l.M concentration of each retinoid on collagenase activity in the medium per mg cell protein and on total protein synthesis as reflected by a decrease in total newly synthesized 3 H-labeled trichloroacetic acid-precipitable protein (in the medium+ cells) per mg cell protein (Fig 4) . The retinoic acid compounds were the most effective inhibitors of collagenase. No statistically significant difference between 13-cisand all-trans-retinoic acid in terms of collagenase inhibition was noted; however, each compound produced a significantly greater inhibition of collagenase than of total protein synthesis (p < 0.05). The parent compound, retinol, was the least effective agent, while the aromatic retinoid, Ro 10-9359, showed only minor inhibitory capacity. The specificity of the retinoic acid effects on collagenase expression is attested to by the fact that retinol and Ro 10-9359 produced no greater inhibition of collagenase expression than of total protein synthesis.
To gain insight into the possible mechanism(s) for the action of retinoic acid on collagenase production, we measured both collagenase activity and immunoreactive enzyme protein in the culture medium (Table II) . In each case the inhibition of collagenase activity was paralleled by a decrease in immunoreactive protein in the medium. For example, as shown in Experiments I and 2, activity was inhibited 50 and 55% by 10 f.LM 13-cis-retinoic acid, while immunoreactive protein was inhibited 46 and 61%. These results suggest that the retinoids act primarily by inhibiting the synthesis of enzyme protein. In Experiment 2 (Table II) the specificity of this effect was also examined by quantitating the incorporation of ' 1 H -labeled amino acids into 10% trichloroacetic acid-precipitable material in the medium and cells of cultures containing the highest concentration of retinoic acid employed in the studies, 10 J.LM. Compared to the control cultures maintained in the DMSO vehicle alone (396.6 cpm X 10-:J / mg protein), protein synthesis was 274.9 cpm X 10-";mg protein in the presence of 10 f.LM 13cis-retinoic acid (31% inhibition) , 345.2 cpm X 10-3 /mg protein in the presence of 10 J.l.M all-trans-retinoic acid (13% inhibition), and 383.7 cpm X 10-3 / mg protein in the presence of 10 f.LM retinol (3% inhibition). Thus, even at the highest levels of retinoic acid employed for these studies, which produced approximately a 60% decrease in collagenase activity and enzyme protein, there was only half as great a decrease in total protein synthesis in the presence of the 13-cis compound and less than one-fifth the decrease in total protein synthesis in the presence of the all-trans compound.
In some cases (e.g., Table II ture medium for the presence of an inhibitor of collagenase activity. For these studies, crude culture medium derived from cells maintained in the presence of 10 J.LM retinoic acid was added in varying concentrations to a constant amount of fully active, purified human skin collagenase to detect any direct enzyme inhibitory effect. Fig 5 depicts a representative inhibition curve obtained from one such experiment. The concentration-dependent direct inhibition of activity observed suggests that a second mechanism for modulation of collagenase may be present, i.e., that the retinoid may enhance secretion of an inhibitor of collagenase activity.
To explore this ·possibility further, experiments were performed to determine whether the enhanced amount of inhibitor was dependent upon the concentration of retinoid in the culture medium. As shown by the two cell strains in Fig 6, after culturing the fibroblasts in varying concentrations of 13-cisretinoic acid, equivalent volumes of culture medium contained increasingly greater direct collagenase inhibitory capacity as the concentration of retinoid in the growth medium increased. Here, it should be reemphasized that the direct addition of any of the retinoids alone to the enzyme assay did not inhibit activity, and, thus, . the drugs exerted their effects through modulation of cellular function.
In a second series of experiments the phenotypic variability in the expression of this inhibitor was examined (Table III) . Three points emerged from these data. First, considerable variability was observed among cell strains in the expression of this inhibitor. Second, both normal and RDEB cells had the capacity to secrete this inhibitor into the culture medium. Third, the variability in inhibition among compounds seemed in some cases to be related to the length of time in culture in the presence of retinoid. In particular, at 48 h, 13-cis-retinoic acid was associated with greater expression of inhibition. This effect <;an be seen in Experiments 3, 4, and 5 in which the mean ( ± SE) inhibition per 100 J.L1 of medium was .46. 7 ± 11.1% for 13cis-retinoic acid compared to 11.5 ± 1.5% for all-trans-retinoic acid (p < 0.05). Furthermore, as can be noted in Experiment 5, retinol was less than half as effective as 13-cis-retinoic acid in modulating the expression of the inhibitor.
Initial characterization of the inhibitor found in the retinoic acid cultures revealed it to be a nondialyzable macromolecule which was heat stable when exposed to h eating at 60°C for 20 min. These characteristics are similar to those reported previously from this laboratory for the inhibitor isolated from normal human skin fibroblast cultures by Welgus et al [26] . In addition, " In each experiment, a 100-~ portion of medium derived from cultures maintained in t he organic solvent alone (control medium) or from cultures maintained in a 10 I'M concentration of retinoid (retinoid medi um) was added to exogenous, fully active, pw-ified human skin collagenase. T he entire reaction mixture was then assayed at 37°C using a radioactive collagen substrate. The results are expressed as the inhibition of activity by the retinoid-containing medium over t hat seen in the con trol medium. In these experiments the enzyme activity of. the exogenous collagenase + control medium was 550-1300 cpm. RA, retinoic acid. Varying concentrations of inhibitor-containing medium partially pUl'ified by passage over CM-cellulose were added to fu lly active, purified hu man skin collagenase a nd the entire mixture was assayed at 37°C for 1 h using radioactive substrate. The data ar e presented as % inhibit ion achieved relative to t he enzyme activity seen in a reaction mixture con taining no inhibitor (589 cpm above blank). derived culture medium (Fig 5) , the material partially pmified by its failme to bind to CM-cellulose gave a dose-dependent inhibition of collagenase activity (Fig 7) . This preparation inhibited t he gelatinolytic protease as well, with 25 0 of t h e CMcellulose fall-thro ugh producing an ~35 % inhibition of activity. This observation also suggests that t h e inhibitor being modulated in the retinoid cultures was the fibroblast-derived inhibitor fou nd in normal cultmes, since human skin gelatinase is known to be inhibited by this protein [7] .
DISCUSSION
A major differentiated function of skin fibroblasts is to synthesize and secrete collagenase, as shown by t he fact that up to 1% of the biosynthetic capacity of these cells is devoted to this process [27) . In the present studies, we h ave shown that certain derivatives of vitamin A exert profound effects on human skin fibroblasts, t hus altering t h e synthesis of a major gene product of the cells. Unlike the effects of these agents on epith elial cells, however, many of which are mediated through growth and/ or differentiation [28] , th e effects on collagenase were observed under conditions independent of cellular growth , i.e., in serumfree confluent cultmes.
The degree of inhibit~on of collagenase expression elicited by retinoic acid in human skin fibroblast cultmes was similar to t hat observed by Brinckerhoff et al [11] in cultmes of rheumatoid synovial cells. It sh ould be emphasized, however, that certain observations, which may in part reflect inherent differences between t h e synovial cell and skin fibroblast systems, have emerged from om studies. First, in contrast to the synovial cells (11] , human skin fibroblasts elaborate a gelatinolytic pro-tease. Although other cells and tissues have been shown to contain gelatinolytic enzymes [3] [4] [5] [6] , within the context of connective tissue turnover in normal skin, it is reasonable to hypothesize that the gelatinase found in cultured skin [7] may represent the enzyme for completing collagen degradation after the rate-limiting step involving collagenase. Thus, the effect that retinoic acid exerted on gelatinase expression-although occurring only at a higher concentration than that required to inhibit collagenase (Fig 2) -underscores the potential for this class of compounds as pharmacologic modulators at two levels of connective tissue degradation.
By measuring immunoreactive collagenase protein in the culture medium (Table II) , we have shown that the retinoic acid-mediated decrease in trypsin-activatable collagenase was accompanied by a parallel decrease in enzyme protein. We have previously demonstrated that under normal biosynthetic conditions there is little intracellular storage of collagenase, and that the rate of secretion of enzyme protein into the medium is reflective of de novo synthesis; indeed, after 12-24 h in culture more than 85% of the enzyme protein is found in the culture medium [27] . Thus, although detailed biosynthetic studies will ultimately be required to assign a specific cellular mechanism of action for these drugs on collagenase, the data suggest that the retinoic acids act primarily by inhibiting synthesis of the enzyme. The specificity of this effect is supported by the observation that at a concentration of 1 p.M retinoic acid-a level that produced approximately half-maximal inhibition of collagenase expression-there was no more than an 11% inhibition of total protein synthesis (Fig 4) . Furthermore, with both collagenase and the gelatinolytic protease, even a 10 J.LM concentration of 13-cis-retinoic acid produced only half as great an inhibition of total protein synthesis (31% inhibition) as of the expression of these enzymes (50-80% inhibition).
It should be noted, however, that inhibition of enzyme synthesis need not be the only mechanism for modulating collagenase action. In some cell strains, in contrast to the rheumatoid synovial cell system [11] , we observed a greater reduction in collagenase activity than could be accounted for solely by a decrease in enzyme protein. By simple "add-back" experiments in which media derived from cultures maintained in retinoids were added to fully active collagenase, the presence of an inhibitor was documented (Figs 5-7, Table III ). The appearance of this inhibitor was dependent upon the concentration of retinoic acid in the medium, since about 3 times as much was seen in cultures maintained in 10 p.M 13-cis-retinoic acid as in those maintained in 0.1 J.LM 13-cis-retinoic acid ( Fig 6) . Because of the thermal stability and behavior on CM-cellulose of this inhibitory macromolecule, it is likely that it is identical to the inhibitor isolated previously from unperturbed cultures of human skin fibroblasts [26] . Although a number of collagenase inhibitors which share certain, but not all, characteristics has been isolated from various tissue sources [29] [30] [31] [32] [33] [34] [35] [36] [37] , the differences in these inhibitors may reflect the existence of tissuespecific minor variations. Thus, it would be of interest to assess the modulatory potential of the various retinoids on the expression of other tissue inhibitors.
The fact that the retinoic acids-especially 13-cis-retinoic acid-exert their effects on collagenase by two different mechanisms may hav:e important therapeutic implications in RDEB. In this disorder, both morphologic [38] and biochemical [16, 17, 39, 40] evidence suggest that the blistering and tissue fragility may in part result from increased synthesis of collagenase. Indeed, the anticonvulsant drug, phenytoin, which inhibits collagenase expression in vitro [15] , has been shown to ameliorate blistering when given clinically [15, 18] . Thus, it is reasonable to postulate that drugs that decrease collagenase synthesis or activity might be therapeutically useful in the disease. In the case of the retinoic acids compounds, the evidence accumulated here would speak for a dual rationale for pharmacologic intervention with retinoic acid-decreased synthesis of enzyme pro-Vol. 81, No . 2 tein and enhanced expression of an inhibitor. Furthermore, the levels of retinoic acid used in this study (0.1 p.M "" 30 ng/ml) should be pharmacologically achievable, since the normal plasma concentration of retinoic acid is 1-3 ng/ml [ 41] .
